157 related articles for article (PubMed ID: 26448056)
1. Cardiac Toxicity in Selective Serotonin Reuptake Inhibitor Users.
Lusetti M; Licata M; Silingardi E; Reggiani Bonetti L; Palmiere C
Am J Forensic Med Pathol; 2015 Dec; 36(4):293-7. PubMed ID: 26448056
[TBL] [Abstract][Full Text] [Related]
2. Pathological changes in anabolic androgenic steroid users.
Lusetti M; Licata M; Silingardi E; Reggiani Bonetti L; Palmiere C
J Forensic Leg Med; 2015 Jul; 33():101-4. PubMed ID: 26048507
[TBL] [Abstract][Full Text] [Related]
3. Serotonin syndrome after small doses of citalopram or sertraline.
Voirol P; Hodel PF; Zullino D; Baumann P
J Clin Psychopharmacol; 2000 Dec; 20(6):713-4. PubMed ID: 11106153
[No Abstract] [Full Text] [Related]
4. High-Dose Citalopram and Escitalopram and the Risk of Out-of-Hospital Death.
Ray WA; Chung CP; Murray KT; Hall K; Stein CM
J Clin Psychiatry; 2017 Feb; 78(2):190-195. PubMed ID: 27736049
[TBL] [Abstract][Full Text] [Related]
5. Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis.
Assimon MM; Brookhart MA; Flythe JE
J Am Soc Nephrol; 2019 Apr; 30(4):611-623. PubMed ID: 30885935
[TBL] [Abstract][Full Text] [Related]
6. Proton pump inhibitors may enhance the risk of citalopram- and escitalopram-associated sudden cardiac death among patients receiving hemodialysis.
Assimon MM; Pun PH; Al-Khatib SM; Brookhart MA; Gaynes BN; Winkelmayer WC; Flythe JE
Pharmacoepidemiol Drug Saf; 2022 Jun; 31(6):670-679. PubMed ID: 35285107
[TBL] [Abstract][Full Text] [Related]
7. Serotonin-selective reuptake inhibitor-induced enuresis in three pediatric cases.
Hergüner S; Kilinçaslan A; Görker I; Tüzün U
J Child Adolesc Psychopharmacol; 2007 Jun; 17(3):367-9. PubMed ID: 17630870
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of QT prolongation with serotonin reuptake inhibitors.
Ojero-Senard A; Benevent J; Bondon-Guitton E; Durrieu G; Chebane L; Araujo M; Montastruc F; Montastruc JL
Psychopharmacology (Berl); 2017 Oct; 234(20):3075-3081. PubMed ID: 28770276
[TBL] [Abstract][Full Text] [Related]
9. Differential Associations of Specific Selective Serotonin Reuptake Inhibitors With Resting-State Heart Rate and Heart Rate Variability: Implications for Health and Well-Being.
Kemp AH; Fráguas R; Brunoni AR; Bittencourt MS; Nunes MA; Dantas EM; Andreão RV; Mill JG; Ribeiro AL; Koenig J; Thayer JF; Benseñor IM; Lotufo PA
Psychosom Med; 2016 Sep; 78(7):810-8. PubMed ID: 27219492
[TBL] [Abstract][Full Text] [Related]
10. The emergence of tics during escitalopram and sertraline treatment.
Altindag A; Yanik M; Asoglu M
Int Clin Psychopharmacol; 2005 May; 20(3):177-8. PubMed ID: 15812270
[TBL] [Abstract][Full Text] [Related]
11. Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline.
Stahl SM
Biol Psychiatry; 2000 Nov; 48(9):894-901. PubMed ID: 11074227
[TBL] [Abstract][Full Text] [Related]
12. Incidence of early anxiety aggravation in trials of selective serotonin reuptake inhibitors in depression.
Näslund J; Hieronymus F; Emilsson JF; Lisinski A; Nilsson S; Eriksson E
Acta Psychiatr Scand; 2017 Oct; 136(4):343-351. PubMed ID: 28859218
[TBL] [Abstract][Full Text] [Related]
13. Linezolid interaction with serotonin reuptake inhibitors: report of two cases and incidence assessment.
Go AC; Golightly LK; Barber GR; Barron MA
Drug Metabol Drug Interact; 2010; 25(1-4):41-7. PubMed ID: 21417793
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the FDA warning against prescribing citalopram at doses exceeding 40 mg.
Zivin K; Pfeiffer PN; Bohnert AS; Ganoczy D; Blow FC; Nallamothu BK; Kales HC
Am J Psychiatry; 2013 Jun; 170(6):642-50. PubMed ID: 23640689
[TBL] [Abstract][Full Text] [Related]
15. Association between serotonin 2A receptor (HTR2A), serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene polymorphisms and citalopram/sertraline induced sexual dysfunction in MDD patients.
Oz MD; Baskak B; Uckun Z; Artun NY; Ozdemir H; Ozel TK; Ozguven HD; Suzen HS
Pharmacogenomics J; 2020 Jun; 20(3):443-450. PubMed ID: 31792367
[TBL] [Abstract][Full Text] [Related]
16. Selective Serotonin Reuptake Inhibitor Use and Risk of Arrhythmia: A Nationwide, Population-Based Cohort Study.
Lin YT; Lu TS; Hansen RA; Wang CC
Clin Ther; 2019 Jun; 41(6):1128-1138.e8. PubMed ID: 31178037
[TBL] [Abstract][Full Text] [Related]
17. [The transfer of selective serotonin reuptake inhibitors to human milk].
Nordeng H; Bergsholm YK; Bøhler E; Spigset O
Tidsskr Nor Laegeforen; 2001 Jan; 121(2):199-203. PubMed ID: 11475200
[TBL] [Abstract][Full Text] [Related]
18. Alopecia associated with treatment with selective serotonin reuptake inhibitors (SSRIs).
Hedenmalm K; Sundström A; Spigset O
Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):719-25. PubMed ID: 16783834
[TBL] [Abstract][Full Text] [Related]
19. [Selective serotonin reuptake inhibitors and mammary pathologies].
Shchepotin IB; Zotov AS; Dobzhenko MN
Vopr Onkol; 2010; 56(4):393-7. PubMed ID: 20968014
[No Abstract] [Full Text] [Related]
20. Repetition of serotonin syndrome after reexposure to SSRI--a case report.
Tomaselli G; Modestin J
Pharmacopsychiatry; 2004 Sep; 37(5):236-8. PubMed ID: 15359377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
